MAIMONIDES MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1911-01-01

Employees: 5K

Market Cap: -

Website: http://www.maimonidesmed.org

Clinical Trials

The Impact of Suctioning on Oxygenation During RSI in the Emergency Department

Phase 4

Completed

Conditions: RSI

First Posted Date: 2024-10-31

Last Posted Date: 2024-11-04

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 76

Registration Number: NCT06667336

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Intracervical Balloon Placement With Nitrous Oxide Administration

Phase 3

Recruiting

Conditions: Induced; Birth
Labor Pain

Interventions: Drug: Nitrous oxide
Drug: Oxygen

First Posted Date: 2024-07-12

Last Posted Date: 2024-07-12

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 162

Registration Number: NCT06498908

Locations: 🇺🇸
Maimonides Medical Center OB/GYN, Brooklyn, New York, United States

Maimonides Minocycline in Stroke Study

Phase 2

Recruiting

Conditions: Hemorrhagic Stroke
Stroke, Acute
Morbidity
Ischemic Stroke
Mortality

Interventions: Drug: Minocycline

First Posted Date: 2023-10-30

Last Posted Date: 2023-11-18

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 1120

Registration Number: NCT06107725

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Fibulink Syndesmosis Repair System With Early Full-Weight Bearing

Not Applicable

Recruiting

Conditions: Ankle Dislocation
Bimalleolar Fractures
Syndesmotic Injuries
Bimalleolar Equivalent Fracture
Ankle Fractures
Trimalleolar Fractures
Maisonneuve Fracture

Interventions: Other: Early Weight Bearing
Other: Normal Weight Bearing

First Posted Date: 2023-10-17

Last Posted Date: 2024-10-22

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 56

Registration Number: NCT06085586

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Impact of Bright Light Therapy on Prader-Willi Syndrome

Not Applicable

Recruiting

Conditions: Prader-Willi Syndrome
Behavior
Hyperphagia
Body Weight
Excessive Daytime Sleepiness
Mood

Interventions: Other: Sham Light
Other: Bright Light Therapy

First Posted Date: 2023-07-11

Last Posted Date: 2023-11-14

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 30

Registration Number: NCT05939453

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Hyper Adduction of Right Radial Artery/Arm vs Left Drag Over Technique

Recruiting

Conditions: Radiation Exposure

Interventions: Diagnostic Test: Cardiac Catheterization

First Posted Date: 2023-04-27

Last Posted Date: 2023-07-06

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 534

Registration Number: NCT05833516

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Vaginal Cuff Infiltration With Liposomal Bupivacaine for Pain Relief: A Double Blind, Randomized Controlled Trial

Phase 4

Recruiting

Conditions: Postoperative Pain

Interventions: Drug: Exparel with Bubivacaine
Drug: Bupivacaine only

First Posted Date: 2023-04-21

Last Posted Date: 2023-04-24

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 80

Registration Number: NCT05823363

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome

Phase 4

Completed

Conditions: Prader-Willi Syndrome
Aggression
Self-Injurious Behavior
Pathologic Processes
Behavioral Symptoms
Intellectual Disability
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Abnormalities, Multiple

Interventions: Other: Placebo
Drug: Guanfacine Extended Release

First Posted Date: 2022-12-20

Last Posted Date: 2024-08-19

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 15

Registration Number: NCT05657860

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Phase 4

Completed

Conditions: Ketamine
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics, Non-Narcotic
Treatment Resistant Depression
Analgesia
Neurotransmitter Agents
Anti-Inflammatory Agents
Depressive Symptoms
Major Depressive Disorder

Interventions: Drug: VTS-K

First Posted Date: 2022-11-14

Last Posted Date: 2024-06-07

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 15

Registration Number: NCT05615948

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Using Dexmedetomidine Prior to Intubation in Neonates

Phase 3

Recruiting

Conditions: Effect Neonatal

Interventions: Other: Usual Care
Drug: Dexmedetomidine

First Posted Date: 2022-03-31

Last Posted Date: 2023-10-24

Lead Sponsor: Maimonides Medical Center

Target Recruit Count: 30

Registration Number: NCT05304598

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy